Pfizer Buys 40% of Brazilian Drug Maker Teuto

by Savitha C Muppala on  October 23, 2010 at 12:42 AM Corporate News
RSS Email Print This Page Comment
Pfizer, US pharmaceutical giant, has bought 40 percent of Brazilian drug company Teuto for a whopping 238 million dollars.

The purchase could lead to the 100-percent acquisition of Teuto in 2014, it said in a statement.
 Pfizer Buys 40% of Brazilian Drug Maker Teuto
Pfizer Buys 40% of Brazilian Drug Maker Teuto

The 40-percent stake "allows Pfizer to increase its participation in Brazil's pharmaceutical market," the head of Pfizer Brazil, Victor Mezei, said in the statement.

He explained that the deal could result in Teuto producing generic versions of Pfizer medicines, and Pfizer using Teuto products in its output.

Pfizer is the world's second-biggest pharmaceutical company in the world after US rival Johnson & Johnson, according to Fortune magazine.

The maker of Viagra to treat erectile dysfunction and Lipitor to lower cholesterol, it had 2009 revenues of 50 billion dollars and profits of 8.6 billion dollars.

Pfizer Brazil generated 703 million dollars in revenues last year.

Source: AFP

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Signature Drug Toxicity Top Ten Selling Drugs 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive